Intrinsic Value of S&P & Nasdaq Contact Us

Vaxart, Inc. VXRT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
$0.65
-7.1%
Analyst Price Target
$2.00
+185.7%

Vaxart, Inc. (VXRT) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.

The consensus price target is $2.00, representing an upside of 185.7% from the current price $0.70.

Analysts estimate Earnings Per Share (EPS) of $-0.39 and revenue of $0.03B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.03 vs est $-0.39 (beat +91.4%). 2025: actual $0.07 vs est $-0.28 (beat +125%). Analyst accuracy: 0%.

VXRT Stock — 12-Month Price Forecast

$2.00
▲ +185.71% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Vaxart, Inc., the price target is $2.00.
The average price target represents a +185.71% change from the last price of $0.70.

VXRT Analyst Ratings

Buy
3
Ratings
3 Buy
Based on 3 analysts giving stock ratings to Vaxart, Inc. in the past 3 months
Rating breakdown
Buy
3 100%
100%
Buy
3 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — VXRT

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$0.03 vs Est –$0.39 ▲ 1,068.2% off
2025 Actual $0.07 vs Est –$0.28 ▲ 500.0% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. EPS trend is improving.

Revenue Estimates — VXRT

45%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.029B vs Est $0.034B ▼ 19.5% off
2025 Actual $0.237B vs Est $0.022B ▲ 90.9% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message